Diseases of Pulmonary Vasculature
Right atrium enlargement may predict the risk for supraventricular arrhythmias in patients with pulmonary arterial hypertension.
Women with pulmonary arterial hypertension may have better long-term prognoses compared with men, potentially because of improvements in right ventricular function.
Varicose veins significantly increased the risk for deep vein thrombosis and may also increase the risk for pulmonary embolism and peripheral artery disease.
A 3-month risk for a thromboembolic event was assessed using a pulmonary embolism rule-out criteria strategy and compared with a conventional strategy in patients with a low clinical probability of pulmonary embolism.
Acute pulmonary embolism may be managed in an outpatient setting when the patient has a low risk for mortality.
Hypoxemia is associated with reduced survival in patients with idiopathic or heritable pulmonary arterial hypertension.
Peak circulatory may provide reliable prognostic information in patients with idiopathic pulmonary arterial hypertension.
The 6MWT is a clinically relevant and appropriate target for patients with pulmonary arterial hypertension.
Certain risk scores may not be reliable for predicting the presence of a pulmonary embolism in pregnant or postpartum women.
To minimize the "learning effect" and improve accuracy, patients with suspected pulmonary hypertension should undergo two 6-minute walk tests.
A pilot study will assess the effectiveness of milrinone in a small group of infants born with congenital diaphragmatic hernia.
Compared with age, pulmonary hypertension, right ventricular failure, and cardiopulmonary bypass time may better predict outcomes in heart transplantation.
Treprostinil, a prostacyclin derivative, used in an implantable delivery system may be an effective treatment alternative for pulmonary arterial hypertension.
Researchers examined the effect of riociguat compared with placebo on the REVEAL risk score and long-term outcomes for pulmonary arterial hypertension.
Smoke-free ordinances may reduce the number of lung cancer cases.
A decrease in baseline estimated glomerular filtration rate in PAH may be a predictor of hospitalization and mortality.
Catheter-directed thrombolysis vs systemic thrombolysis strategies show different risk outcomes for patients with intermediate-risk pulmonary embolism.
Several clinical predictors of pediatric pulmonary embolism have been identified.
A 40-year-old woman presents with worsening shortness of breath after being treated with long-acting nifedipine for 2 years.
Exercise intolerance is a hallmark symptom of pulmonary arterial hypertension.
Patients with pulmonary arterial hypertension may have an impaired cerebral pressure-flow relationship.
Switching from a phosphodiesterase type 5 inhibitor to riociguat significantly improves pulmonary arterial compliance in patients with PAH.
Pulmonary artery compliance may be an independent predictor of survival and prognosis in patients with pulmonary artery hypertension associated with congenital heart disease.
Nebulized glycopyrrolate improves lung function and patient-reported outcomes in patients with moderate to very severe COPD.
Pulmonary arterial hypertension associated with the use of methamphetamine is a severe, progressive form of the disease.
Patients with hereditary hemorrhagic telangiectasia may develop pulmonary hypertension.
Patients with chronic thromboembolic pulmonary hypertension may have higher rates of depression compared to patients with PAH.
Having at least 2 features of pulmonary veno-occlusive disease is linked to reduced survival rate in patients with SSc and PAH.
Borderline pulmonary hypertension is associated with increased risk of mortality in patients undergoing right heart catheterization.
Development of CTEPH is associated with traditional thrombotic risk factors, including thrombophilias and inflammatory processes.
The Cardiology Advisor Articles
- AHA/ACC: Updated Management Guidelines for Adult Congenital Heart Disease
- American Heart Association Urges Screen Time Limits for Youth
- Patient Connectivity Benefits Familial Chylomicronemia Syndrome
- Exercise Benefits for Myocardial Infarction Not Reduced by Traffic Pollutants
- Perspectives on USPSTF Afib Screening Recommendation
- Apixaban Lowers Bleeding Risk in Afib With End-Stage Kidney Disease
- Tricuspid Regurgitation Velocity Unreliable Indicator of Pulmonary Hypertension
- Supplementing Pulmonary Arterial Hypertension Therapy With Nutritional Changes
- The Challenge of Compassion in Modern Healthcare Settings
- Concomitant NSAID and Anticoagulant Use May Increase Stroke, Bleeding Risk in Afib
- AHA Issues Scientific Statement on Managing Chagas Cardiomyopathy
- Genetic Screening in Preventive Care: Advances and Challenges
- No Impact on Carotid Artery Intima-Media Thickness Following Cessation of Menopausal Hormone Therapy
- Cardiovascular Event Rates Vary by Kidney Failure Cause
- Weight Gain After Quitting Smoking May Increase T2DM Risk